Published in Nephrol Dial Transplant on January 01, 2002
Hemodialysis-induced cardiac injury: determinants and associated outcomes. Clin J Am Soc Nephrol (2009) 3.19
Endotoxemia is related to systemic inflammation and atherosclerosis in peritoneal dialysis patients. Clin J Am Soc Nephrol (2008) 1.65
Markers of inflammation predict the long-term risk of developing chronic kidney disease: a population-based cohort study. Kidney Int (2011) 1.53
Health-related quality of life in different stages of chronic kidney disease and at initiation of dialysis treatment. Health Qual Life Outcomes (2012) 1.22
Prognostic value of reduced left ventricular ejection fraction at start of hemodialysis therapy on cardiovascular and all-cause mortality in end-stage renal disease patients. Clin J Am Soc Nephrol (2010) 1.09
Fatigue is a predictor for cardiovascular outcomes in patients undergoing hemodialysis. Clin J Am Soc Nephrol (2010) 1.03
Plasma adiponectin levels and clinical outcomes among haemodialysis patients. Nephrol Dial Transplant (2008) 0.97
Nasal carriage of methicillin-resistant Staphylococcus aureus is associated with higher all-cause mortality in hemodialysis patients. Clin J Am Soc Nephrol (2010) 0.93
Prevalence and risk factors of fluid overload in Southern Chinese continuous ambulatory peritoneal dialysis patients. PLoS One (2013) 0.92
The relationship between epicardial adipose tissue and malnutrition, inflammation, atherosclerosis/calcification syndrome in ESRD patients. Clin J Am Soc Nephrol (2011) 0.92
Association of hsCRP, white blood cell count and ferritin with renal outcome in chronic kidney disease patients. PLoS One (2012) 0.92
Calcification of the aortic arch predicts cardiovascular and all-cause mortality in chronic hemodialysis patients. Cardiorenal Med (2014) 0.88
Role of dyslipidemia in impairment of energy metabolism, oxidative stress, inflammation and cardiovascular disease in chronic kidney disease. Clin Exp Nephrol (2013) 0.87
High-calorie diet with moderate protein restriction prevents cachexia and ameliorates oxidative stress, inflammation and proteinuria in experimental chronic kidney disease. Clin Exp Nephrol (2010) 0.86
Anti-Inflammatory and Anti-Oxidative Nutrition in Hypoalbuminemic Dialysis Patients (AIONID) study: results of the pilot-feasibility, double-blind, randomized, placebo-controlled trial. J Cachexia Sarcopenia Muscle (2013) 0.85
Risk factors for mortality in Chinese patients on continuous ambulatory peritoneal dialysis. Perit Dial Int (2014) 0.85
Chronic kidney disease and inflammation in pediatric patients: from bench to playground. Pediatr Nephrol (2005) 0.84
Impact of living environment on 2-year mortality in elderly maintenance hemodialysis patients. PLoS One (2013) 0.84
Malnutrition, renal dysfunction and left ventricular hypertrophy synergistically increase the long-term incidence of cardiovascular events. Hypertens Res (2016) 0.84
Assessment of nutritional status in children with chronic kidney disease and on dialysis. Pediatr Nephrol (2013) 0.84
Health-related quality-of-life after percutaneous coronary intervention in patients with UA/NSTEMI and STEMI: the Korean multicenter registry. J Korean Med Sci (2013) 0.83
Factors affecting effectiveness of vaccination against hepatitis B virus in hemodialysis patients. World J Gastroenterol (2014) 0.82
High mobility group box protein-1 correlates with microinflammatory state and nutritional status in continuous ambulatory peritoneal dialysis patients. J Artif Organs (2011) 0.82
The malnutrition and inflammation axis in pediatric patients with chronic kidney disease. Pediatr Nephrol (2007) 0.82
Higher peritoneal protein clearance as a risk factor for cardiovascular disease in peritoneal dialysis patient. PLoS One (2013) 0.81
Apolipoprotein E polymorphism in hemodialyzed patients and healthy controls. Biochem Genet (2009) 0.80
Nutritional and inflammatory axis of racial survival disparities. Semin Dial (2012) 0.80
Insulin resistance is associated with new-onset cardiovascular events in nondiabetic patients undergoing peritoneal dialysis. Kidney Res Clin Pract (2014) 0.79
Inflammation and L-carnitine therapy in hemodialysis patients: a review. Clin Exp Nephrol (2014) 0.79
The Predictive Role of Serum Triglyceride to High-Density Lipoprotein Cholesterol Ratio According to Renal Function in Patients with Acute Myocardial Infarction. PLoS One (2016) 0.77
Heart failure and kidney dysfunction: epidemiology, mechanisms and management. Nat Rev Nephrol (2016) 0.77
Pretransplant malnutrition, inflammation, and atherosclerosis affect cardiovascular outcomes after kidney transplantation. BMC Nephrol (2015) 0.77
Cytokines in chronic kidney disease: potential link of MCP-1 and dyslipidemia in glomerular diseases. Pediatr Nephrol (2012) 0.76
The association of uremic toxins and inflammation in hemodialysis patients. PLoS One (2014) 0.76
Hyponatremia Predicts New-Onset Cardiovascular Events in Peritoneal Dialysis Patients. PLoS One (2015) 0.76
Lacking evidence for calcium-binding protein fetuin-A to be linked with chronic kidney disease-related pruritus (CKD-rP). NDT Plus (2010) 0.76
Linagliptin monotherapy compared with voglibose monotherapy in patients with type 2 diabetes undergoing hemodialysis: a 12-week randomized trial. BMJ Open Diabetes Res Care (2016) 0.75
Transcriptomics: A Step behind the Comprehension of the Polygenic Influence on Oxidative Stress, Immune Deregulation, and Mitochondrial Dysfunction in Chronic Kidney Disease. Biomed Res Int (2016) 0.75
Serum C-reactive protein levels in pre-dialysis chronic kidney disease patientsin southern Nigeria. Ghana Med J (2016) 0.75
The Diet and Haemodialysis Dyad: Three Eras, Four Open Questions and Four Paradoxes. A Narrative Review, Towards a Personalized, Patient-Centered Approach. Nutrients (2017) 0.75
Extracellular Fluid/Intracellular Fluid Volume Ratio as a Novel Risk Indicator for All-Cause Mortality and Cardiovascular Disease in Hemodialysis Patients. PLoS One (2017) 0.75
Nutritional Status in Adults with Predialysis Chronic Kidney Disease: KNOW-CKD Study. J Korean Med Sci (2017) 0.75
Malnutrition in pre-dialysis chronic kidney disease patients in a teaching hospital in Southern Nigeria. Afr Health Sci (2016) 0.75
Lower serum potassium associated with increased mortality in dialysis patients: A nationwide prospective observational cohort study in Korea. PLoS One (2017) 0.75
Gene expression changes in venous segment of overflow arteriovenous fistula. Int J Nephrol (2013) 0.75
Effect of selenium supplementation on lipid profile in hemodialysis patients. J Renal Inj Prev (2016) 0.75
Effects of statin therapy on clinical outcomes after acute myocardial infarction in patients with advanced renal dysfunction: A propensity score-matched analysis. PLoS One (2017) 0.75
Association between periodontal disease and mortality in people with CKD: a meta-analysis of cohort studies. BMC Nephrol (2017) 0.75
The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia. Kidney Int (2002) 4.29
Genetic loci influencing kidney function and chronic kidney disease. Nat Genet (2010) 3.75
Review on uremic toxins: classification, concentration, and interindividual variability. Kidney Int (2003) 3.54
Protein-energy wasting modifies the association of ghrelin with inflammation, leptin, and mortality in hemodialysis patients. Kidney Int (2010) 3.53
Emerging biomarkers for evaluating cardiovascular risk in the chronic kidney disease patient: how do new pieces fit into the uremic puzzle? Clin J Am Soc Nephrol (2008) 2.96
IL-10, IL-6, and TNF-alpha: central factors in the altered cytokine network of uremia--the good, the bad, and the ugly. Kidney Int (2005) 2.78
Influence of peritoneal transport rate, inflammation, and fluid removal on nutritional status and clinical outcome in prevalent peritoneal dialysis patients. Perit Dial Int (2003) 2.69
Aspects of immune dysfunction in end-stage renal disease. Clin J Am Soc Nephrol (2008) 2.44
Low fetuin-A levels are associated with cardiovascular death: Impact of variations in the gene encoding fetuin. Kidney Int (2005) 2.42
Biosimilars and biopharmaceuticals: what the nephrologists need to know--a position paper by the ERA-EDTA Council. Nephrol Dial Transplant (2008) 2.42
Plasma pentraxin 3 in patients with chronic kidney disease: associations with renal function, protein-energy wasting, cardiovascular disease, and mortality. Clin J Am Soc Nephrol (2007) 2.19
Associations between circulating inflammatory markers and residual renal function in CRF patients. Am J Kidney Dis (2003) 2.17
Oxidative stress in end-stage renal disease: an emerging threat to patient outcome. Nephrol Dial Transplant (2003) 2.10
Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD. Am J Kidney Dis (2006) 2.09
Comparison of nutritional and inflammatory markers in dialysis patients with reduced appetite. Am J Clin Nutr (2007) 2.07
Interleukin-6 is an independent predictor of mortality in patients starting dialysis treatment. Nephrol Dial Transplant (2002) 2.05
Inflammation, malnutrition, and cardiac disease as predictors of mortality in hemodialysis patients. J Am Soc Nephrol (2002) 2.03
N‑terminal pro‑B-type natriuretic peptide as a marker of hypervolemia and predictor of increased mortality in patients on hemodialysis. Pol Arch Med Wewn (2015) 2.02
[In Process Citation]. Lakartidningen (2015) 2.01
Serum visfatin concentration and endothelial dysfunction in chronic kidney disease. Nephrol Dial Transplant (2007) 1.91
J-shaped mortality relationship for uric acid in CKD. Am J Kidney Dis (2006) 1.88
CCR5 deletion protects against inflammation-associated mortality in dialysis patients. J Am Soc Nephrol (2009) 1.88
Etiology of the protein-energy wasting syndrome in chronic kidney disease: a consensus statement from the International Society of Renal Nutrition and Metabolism (ISRNM). J Ren Nutr (2013) 1.85
Inflammation in end-stage renal disease--what have we learned in 10 years? Semin Dial (2010) 1.82
Serum albumin as predictor of nutritional status in patients with ESRD. Clin J Am Soc Nephrol (2012) 1.80
Accelerated lean body mass loss in incident chronic dialysis patients with diabetes mellitus. Kidney Int (2005) 1.80
Systemic and intraperitoneal interleukin-6 system during the first year of peritoneal dialysis. Perit Dial Int (2006) 1.80
A functional variant of the myeloperoxidase gene is associated with cardiovascular disease in end-stage renal disease patients. Kidney Int Suppl (2003) 1.69
The reverse epidemiology of plasma total homocysteine as a mortality risk factor is related to the impact of wasting and inflammation. Nephrol Dial Transplant (2006) 1.65
Short-term effects of bicarbonate/lactate-buffered and conventional lactate-buffered dialysis solutions on peritoneal ultrafiltration: a comparative crossover study. Nephrol Dial Transplant (2008) 1.63
The prognostic impact of fluctuating levels of C-reactive protein in Brazilian haemodialysis patients: a prospective study. Nephrol Dial Transplant (2004) 1.62
Baseline levels and trimestral variation of triiodothyronine and thyroxine and their association with mortality in maintenance hemodialysis patients. Clin J Am Soc Nephrol (2012) 1.61
Body fat mass and serum leptin levels influence epoetin sensitivity in patients with ESRD. Am J Kidney Dis (2005) 1.57
Obese sarcopenia in patients with end-stage renal disease is associated with inflammation and increased mortality. Am J Clin Nutr (2007) 1.55
Soluble CD14 levels, interleukin 6, and mortality among prevalent hemodialysis patients. Am J Kidney Dis (2009) 1.54
Determination of high and low molecular weight molecules of icodextrin in plasma and dialysate, using gel filtration chromatography, in peritoneal dialysis patients. Perit Dial Int (2005) 1.53
Nonthyroidal illness: a risk factor for coronary calcification and arterial stiffness in patients undergoing peritoneal dialysis? J Intern Med (2013) 1.47
Redefining metabolic syndrome as a fat storage condition based on studies of comparative physiology. Obesity (Silver Spring) (2013) 1.47
Short-term effects of a new bicarbonate/lactate-buffered and conventional peritoneal dialysis fluid on peritoneal and systemic inflammation in CAPD patients: a randomized controlled study. Perit Dial Int (2008) 1.46
How accurate is the description of transport kinetics in peritoneal dialysis according to different versions of the three-pore model? Perit Dial Int (2008) 1.46
Self-rated appetite as a predictor of mortality in patients with stage 5 chronic kidney disease. J Ren Nutr (2012) 1.43
Diets and enteral supplements for improving outcomes in chronic kidney disease. Nat Rev Nephrol (2011) 1.42
Bicarbonate-based peritoneal dialysis solution has less effect on ingestive behavior than lactate-based peritoneal dialysis solution. Perit Dial Int (2009) 1.41
Role of interleukin-1beta in the development of malnutrition in chronic renal failure patients. Blood Purif (2005) 1.40
Wasting in chronic kidney disease. J Cachexia Sarcopenia Muscle (2011) 1.39
[Ghrelin--new promising treatment in anorexia and catabolic conditions]. Lakartidningen (2010) 1.39
Persistent inflammation as a catalyst for other risk factors in chronic kidney disease: a hypothesis proposal. Clin J Am Soc Nephrol (2009) 1.38
Left ventricular mechanical dyssynchrony in patients with different stages of chronic kidney disease and the effects of hemodialysis. Hemodial Int (2013) 1.38
Muscle atrophy, inflammation and clinical outcome in incident and prevalent dialysis patients. Clin Nutr (2008) 1.38
Prevention and treatment of protein energy wasting in chronic kidney disease patients: a consensus statement by the International Society of Renal Nutrition and Metabolism. Kidney Int (2013) 1.31
Truncal fat mass as a contributor to inflammation in end-stage renal disease. Am J Clin Nutr (2004) 1.30
Comorbidity and acute clinical events as determinants of C-reactive protein variation in hemodialysis patients: implications for patient survival. Am J Kidney Dis (2009) 1.28
Plasma and dialysate IL-6 and VEGF concentrations are associated with high peritoneal solute transport rate. Nephrol Dial Transplant (2002) 1.24
Novel links between the long pentraxin 3, endothelial dysfunction, and albuminuria in early and advanced chronic kidney disease. Clin J Am Soc Nephrol (2008) 1.22
Additive effects of soluble TWEAK and inflammation on mortality in hemodialysis patients. Clin J Am Soc Nephrol (2008) 1.22
Inflammation as a risk factor and target for therapy in chronic kidney disease. Curr Opin Nephrol Hypertens (2011) 1.21
Mortality, malnutrition, and atherosclerosis in ESRD: what is the role of interleukin-6? Kidney Int Suppl (2002) 1.20
Pulmonary hypertension in CKD. Am J Kidney Dis (2012) 1.19
High Mobility Group Box Protein-1 correlates with renal function in chronic kidney disease (CKD). Mol Med (2008) 1.17
Multinutrient oral supplements and tube feeding in maintenance dialysis: a systematic review and meta-analysis. Am J Kidney Dis (2005) 1.17
Combination of crystalloid (glucose) and colloid (icodextrin) osmotic agents markedly enhances peritoneal fluid and solute transport during the long PD dwell. Perit Dial Int (2007) 1.17
Coronary artery disease in end-stage renal disease: no longer a simple plumbing problem. J Am Soc Nephrol (2003) 1.16
Risk factors for cardiovascular disease in patients undergoing peritoneal dialysis. Perit Dial Int (2007) 1.16
The role of oxidative stress in chronic kidney disease. Semin Dial (2009) 1.12
Macrophage inhibitory cytokine-1 (MIC-1/GDF15) and mortality in end-stage renal disease. Nephrol Dial Transplant (2011) 1.12
Adipose tissue and its relation to inflammation: the role of adipokines. J Ren Nutr (2005) 1.11
Endogenous testosterone, endothelial dysfunction, and cardiovascular events in men with nondialysis chronic kidney disease. Clin J Am Soc Nephrol (2011) 1.10
Inflammation and its impact on anaemia in chronic kidney disease: from haemoglobin variability to hyporesponsiveness. NDT Plus (2009) 1.09
Left ventricular function in patients with chronic kidney disease evaluated by colour tissue Doppler velocity imaging. Nephrol Dial Transplant (2005) 1.09